± Reliance Infrastructure has announced Rs10bn share buy-back implying 8.34% shares from public shareholders. (ET)
± Reliance Industries has bid for two deepsea blocks in the Andaman Basin in the Bay of Bengal and four onshore blocks in Rajasthan and Gujarat. (ET)
± Dr Reddy laboratories has launched levocetirizine tablets, a generic version of Belgian drugmaker UCB's allergy drug Xyzal, in the US. (ET)
± Shriram City Union Finance plans to raise Rs7.5bn via issue of non-convertible debentures. (ET)
± ONGC sold a cargo of Sudanese Nile Blend crude at the strongest differential in two years on firm Japanese demand for the medium sweet grade. (BS)
± Coal India has lowered the production target to 440mn tons from 460mn tons for the current fiscal. (BS)
± TCS has bagged an order from Australian financial institution CUA for deployment of its banking solution. (BS)
± Idea would invest Rs42bn in 3G network infrastructure, including erecting around 16,000 towers by March, 2012. (ET)
